Director, Clinical Product Management
Share role
The recipient sees their own assessment. Your profile and score are not shared.
About the role
H1 seeks a Director, Clinical Product Management in Copenhagen on a hybrid, full-time basis. The role leads roadmap execution for a clinical data platform supporting trial design, site selection, and study operations for a major pharmaceutical client. Candidates need 7+ years in product management, senior leadership experience, data product expertise, enterprise stakeholder management, relevant health or clinical domain experience, and fluent English.
Key requirements
- • At least 7 years of relevant experience
- • Required skills: Product management, Product roadmap and strategy, Data product development or management, Stakeholder management, Enterprise or client-embedded delivery, Clinical data workflows, Cross-functional leadership, Product requirements definition, Product metrics and adoption tracking, User research and feedback analysis, Startup or scale-up operations, English fluency
- • Required language: English
- • Work authorization for Denmark may be required
Opportunity details
- • Workplace: Hybrid
- • Employment: Permanent
- • Posted: Jul 17, 2026
- • Original advert language: English
Full vacancy
HealthRoleIQ regularly verifies this opportunity against the employer’s posting and highlights the details relevant to your match.
Employer’s role description
Job title: Director, Clinical Product Management
Department: Product
Team: Product Management
Location: Copenhagen
All locations: Copenhagen
Work type: Full time
Workplace type: hybrid
At H1, we believe access to the best healthcare information is a basic human right. Our mission is to provide a platform that can optimally inform every doctor interaction globally. This promotes health equity and builds needed trust in healthcare systems. To accomplish this our teams harness the power of data and AI-technology to unlock groundbreaking medical insights and convert those insights into action that result in optimal patient outcomes and accelerates an equitable and inclusive drug development lifecycle.